Abstract
While clinical environments are highly focused on COVID-19, reports of missed or delayed treatment for conditions that imitate COVID-19, such as pneumonia caused by the fungus Pneumocystis jirovecii, are emerging. Given the uncertain spectrum of COVID-19 presentations and variable sensitivity of laboratory tests for SARS-CoV-2, there is a risk that, without a high index of suspicion, alternative aetiologies may be overlooked while pursuing a diagnosis of COVID-19. The British HIV Association has been calling for the inclusion of HIV testing in all patients admitted to hospital with suspected COVID-19. In this article we reflect on the importance of including HIV testing to prevent avoidable morbidity and mortality in our patients.
| Original language | English |
|---|---|
| Pages (from-to) | 590-592 |
| Number of pages | 3 |
| Journal | Clinical Medicine, Journal of the Royal College of Physicians of London |
| Volume | 20 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Nov 2020 |
| Externally published | Yes |
Keywords
- COVID-19
- HIV
- PCP
- Pneumocystis jirovecii
- SARSCoV-2